Streetbeat News

Price Targets

HLIT

Raymond James analyst Simon Leopold has upgraded Harmonic (NASDAQ:HLIT) from Outperform to Strong Buy and raised the price target from $15 to $16.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 11:22 am

ADAP

Barclays analyst Peter Lawson has maintained an Underweight rating on Adaptimmune Therapeutics (NASDAQ:ADAP) and lowered the price target from $2 to $1.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:20 am

LUXH

JonesTrading analyst Jacob Stephan has reiterated a 'Buy' rating on LuxUrban Hotels (NASDAQ:LUXH) and maintained a price target of $7.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 11:20 am

PRCH

Keefe, Bruyette & Woods analyst Ryan Tomasello has maintained a 'Market Perform' rating on Porch Group (NASDAQ:PRCH) but lowered the price target from $1.4 to $1.2.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:19 am

PLRX

HC Wainwright & Co. analyst Ed Arce has reiterated a 'Buy' rating on Pliant Therapeutics (NASDAQ:PLRX) and maintained a $50 price target.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 11:19 am

LAW

Needham analyst Scott Berg has reiterated a 'Buy' rating on CS Disco (NYSE:LAW) and maintained a price target of $15.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 11:18 am

BLTE

HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on Belite Bio (NASDAQ:BLTE) and maintained a $55 price target.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 11:17 am

BOXL

Alliance Global Partners analyst Brian Kinstlinger has maintained a 'Buy' rating on Boxlight (NASDAQ:BOXL), but lowered the price target from $14 to $9.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:17 am

LTRN

EF Hutton analyst Michael King has reiterated a 'Buy' rating on Lantern Pharma (NASDAQ:LTRN) and maintained an $11 price target.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 11:16 am

NOTE

EF Hutton analyst Michael Albanese has reiterated a 'Buy' rating on FiscalNote Holdings (NYSE:NOTE) and maintained a $9 price target.

Portfolio Pulse from richadhand@benzinga.com

August 10, 2023 | 11:15 am